Effects of Shenqi Fuxin oral liquid on plasma kaliuretic peptide, myocardial contractility and relaxation of left ventricle and left ventricular remodeling in experimental rats with heart failure after myocardial infarction

Chinese Pharmaceutical Journal

Volumn 40, Issue 21, 2005, Pages 1629-1632

  Ma, Lu ^a   Liu, Jian Gang ^a   Chen, Ke Ji ^a   Shi, Da Zhuo ^a   Xue, Qiao ^b   Li, Yang ^b   Gao, Wei ^b  

^a XIYUAN HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Heart failure; Kaliuretic peptide; Myocardial infarction; Shenqi Fuxin oral liquid; Ventricular remodeling

Indexed keywords

BIOASSAY; CARDIOLOGY; CELLS; DOSIMETRY; IMMUNOLOGY; MORPHOLOGY; POLYPEPTIDES;

HEART FAILURE (HF); KALIURETIC PEPTIDE (KP); VENTRICLE;

DRUG PRODUCTS;

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CHINESE DRUG; COLLAGEN; ENDOTHELIN 1; KALIURETIC PEPTIDE; PEPTIDE; SHENQI FUXIN ORAL LIQUID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CELL NUCLEUS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HEART CATHETERIZATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE CONTRACTILITY; HEART MUSCLE RELAXATION; HEART VENTRICLE REMODELING; HEMODYNAMICS; MORPHOLOGY; NONHUMAN; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT;

EID: 32344438796     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Dickstein K, Larsen AI, Bonarjee V. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure[J]. Am J Cardiol, 1995, 766(10):679.
2. Martinez L, Carmona L, Villalobos-Molina R, et al. Vascular alpha 1D-adrenoceptor function is maintained during congestive heart failure after myocardial infarction in the rat[J]. Arch Med Res, 1999, 30 (4):290.
3. Michner ML, Gierse JK, Seetharam H, et al. Proteolvtic processing of atriopeptin prohormone[J]. Mol Pharmacol, 1986, 30:552.
4. Jugdutl BI, Amy RWM. Healing after myocardial infarction in the dog:changes in infarrt hydroxyproline and topography[J]. JACC, 1986, 7(1):91.
5. Dickstein K, Larsen AI, Bonarjee V, et al. Pro-atrial natriuretic factor is predictive for the clinical status of patients with heart failure[J]. Tidsskr Nor Laegeforen, 1996, 116(13):1562.
6. Willette RN, Anderson KM, Nelson AH, et al. Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction[J]. J Cardiovasc Pharmacol, 2001, 38(4):606.
7. Vesel DL, Ovid L, San Mignel, et al. Intact negative feedback of four cardiac hormones in congestive heart failure[J]. Metabolism, 2002, 51(5):582.
8. Vesely DL, Chiou S, Dougalass MA, et al. Atrial natriuretic peptides negatively and positively modulate circulating endothelin in humans [J]. Metabolism, 1996, 45(3):315.